Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 01  •  04:00PM ET
15.50
Dollar change
-0.14
Percentage change
-0.90
%
Category
US Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
40.40%
Total Holdings
15
Perf Week
-10.25%
Sponsor
Elevate Shares
ETF Type
Tags
Return% 3Y
-
AUM
87.36M
Perf Month
-15.53%
Fund Family
Bond Type
Tags
Return% 5Y
-
NAV/sh
Perf Quarter
-17.99%
Index
-
Average Maturity
Tags
Return% 10Y
52W High
27.50 -43.64%
Perf Half Y
-1.90%
Index Weighting
Commodity Type
Tags
Return% SI
52W Low
13.60 13.97%
Perf YTD
5.44%
Active/Passive
Quant Type
Tags
-
Flows% 1M
-22.38%
Volatility
5.53% 4.03%
Perf Year
-38.74%
ESG Type
Tags
-
Flows% 3M
21.99%
ATR (14)
0.82
Perf 3Y
-
Dividend Type
Sector/Theme
Flows% YTD
24.28%
RSI (14)
27.99
Perf 5Y
-
Structure Type
Region
Flows% 1Y
Beta
0.00
Perf 10Y
-
Expense
1.00%
Growth/Value
SMA20
-12.37%
Flows% 3Y
Rel Volume
1.38
Prev Close
15.64
Inverse/Leveraged
Market Cap
SMA50
-17.18%
Flows% 5Y
Avg Volume
230.95K
Price
15.50
IPO
Oct 24, 2023
Option/Short
Yes / Yes
SMA200
-14.05%
Trades
Volume
317,621
Change
-0.90%
YieldMax MRNA Option Income Strategy ETF seeks current income; exposure to the share price of the common stock of Moderna, Inc. ("MRNA"), subject to a limit on potential investment gains is the secondary consideration. The fund advisor will seek to employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. The fund is non-diversified.